Azapropazone

Azapropazone

Clinical data
Trade names	Rheumox
AHFS/Drugs.com	International Drug Names
ATC code	M01AX04 (WHO)
Legal status
Legal status	UK: POM (Prescription only)
Pharmacokinetic data
Elimination half-life	20 hours
Identifiers
IUPAC name (RS)-5-dimethylamino-9-methyl-2-prop-2-enylpyrazolo[1,2-a][1,2,4]benzotriazine-1,3-dione
CAS Number	13539-59-8 N
PubChem CID	26098
ChemSpider	24310 Y
UNII	K2VOT966ZI
KEGG	D02966 Y
ChEBI	CHEBI:38010 Y
ChEMBL	ChEMBL1231131 N
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C16H20N4O2
Molar mass	300.36 g/mol
3D model (JSmol)	Interactive image
SMILES O=C3N/1N(c2c(\N=C\1N(C)C)ccc(c2)C)C(=O)C3CCC
InChI InChI=1S/C16H20N4O2/c1-5-6-11-14(21)19-13-9-10(2)7-8-12(13)17-16(18(3)4)20(19)15(11)22/h7-9,11H,5-6H2,1-4H3 Y Key:MPHPHYZQRGLTBO-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

WikiDoc Resources for Azapropazone
Articles
Most recent articles on Azapropazone Most cited articles on Azapropazone Review articles on Azapropazone Articles on Azapropazone in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Azapropazone Images of Azapropazone Photos of Azapropazone Podcasts & MP3s on Azapropazone Videos on Azapropazone
Evidence Based Medicine
Cochrane Collaboration on Azapropazone Bandolier on Azapropazone TRIP on Azapropazone
Clinical Trials
Ongoing Trials on Azapropazone at Clinical Trials.gov Trial results on Azapropazone Clinical Trials on Azapropazone at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Azapropazone NICE Guidance on Azapropazone NHS PRODIGY Guidance FDA on Azapropazone CDC on Azapropazone
Books
Books on Azapropazone
News
Azapropazone in the news Be alerted to news on Azapropazone News trends on Azapropazone
Commentary
Blogs on Azapropazone
Definitions
Definitions of Azapropazone
Patient Resources / Community
Patient resources on Azapropazone Discussion groups on Azapropazone Patient Handouts on Azapropazone Directions to Hospitals Treating Azapropazone Risk calculators and risk factors for Azapropazone
Healthcare Provider Resources
Symptoms of Azapropazone Causes & Risk Factors for Azapropazone Diagnostic studies for Azapropazone Treatment of Azapropazone
Continuing Medical Education (CME)
CME Programs on Azapropazone
International
Azapropazone en Espanol Azapropazone en Francais
Business
Azapropazone in the Marketplace Patents on Azapropazone
Experimental / Informatics
List of terms related to Azapropazone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Azapropazone is a non-steroidal anti-inflammatory drug. It is manufactured by Goldshield under the tradename Rheumox.

It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects. Azopropazone has now been discontinued in the British National Formulary.

Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.